Investing in pre-revenue start up companies is always very

New Post Public Reply Private Reply Replies (2) Message Board
BarkOLounger newyork11102 #21850
915
Investing in pre-revenue start up companies is always very risky, most of them fail. The reason to do it is everyone once in a while one succeeds and the reward can be staggering.

It seems as though you may have fallen into a common problem, in that you invested money you could not afford to lose, and for that you have my sympathy. That is a hard lesson learned (most of us have learned it over the course of investing).

But the truth is, at this level and this point in the TPAC history, giving effort is about all we can ask for. A few positives I focus on, which make me believe there is still hope are:

1. Bill is still communicating enough for us to know he is healthy and working to make something of TPAC
2. Bill is not communicating any specific or doing anything even remotely resembling pumping for the company.
3. He has made it clear he won't announce anything until a deal is actually done, and revenue booked.

That 3rd is very important IMO, but also very frustrating for us. Based on the last 5 years with TPAC he is wise to keep everything confidential until a material event forces him to file, as past deals and partnerships have been directly sabotaged by people trying to destroy TPAC.

My best guess is that back when TPAC was illegally shorted on foreign markets, a group shorted a bunch of stock and never covered it. They probably want the company to go out of business so they never have to. It's the only explanation that explains to me why a company with no activity for the past 2 years, still gets so much paid basher attention in Ihub (and even here a bit).

All this is IMO, but I haven't written off TPAC yet, I do believe Bill is an honest and honorable man, I believe he is still trying hard to make something of this company, and I believe he has learned many hard lessons over the past 5 or so years that increase his chances of pulling this out.

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading